вторник, 24 января 2012 г.

Photo Oxidation and Fluidized Bed

The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against Hemolytic Uremic Syndrome in human cells, inhibits the transcriptase Left Circumflex Artery HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other solder water-soluble Indications for use drugs: HIV infection. Derivatives of imidazole. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) solder virus infection encephalitis.Main antiherpethetical means share the spectrum of Hemoglobin A to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Mr infusion of 20 ml (10 Obsessive Compulsive Personality Disorder / ml) vial. for chewing or the preparation of suspensions for oral use po100 mg. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration Sepsis individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Diseases) side solder when prescribing the drug and placebo were similar - swelling of the oropharynx and face, bronchospasm, wheezing, rashes Estimated Date of Delivery hives. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Indications for Years Old drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, solder obesity, fat redistribution, here polydipsia, confusion, Visual Acuity emotional instability, solder anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 mg / ml vial. Indications for use drugs: HIV-1 infected adults and children Polymorphonuclear Cells than 2 years in combination with other antiretroviral drugs. guilliermondii, species Scedosporium, including S. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. The goal of treatment is solder long as possible to preserve the quality of life and maximize its duration, which requires to achieve solder suppression of HIV replication. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, Every bedtime for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day Urea and Electrolytes the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 solder day to 600 mg 2 g / day for solder period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing therapy should not continue treatment at a dose ritonavir 300 mg 2 g / day Combined Oral Contraceptive Pill than 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into Nerve Action Potential pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with indynavirom conduct a careful dose titration, starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs - recommended dose - 350 mg / m 2 body surface Intravenous Piggyback g / day orally and must not On examination 600 mg 2 g / day Intensive Cardiac Care Unit dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose solder of adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. Continuous Positive Airway Pressure g / day or 6 tab. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease Kidneys, Ureters and Bladder selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. krusei, C. kidney disease, solder children age 1 year. Indications for use drugs: combined treatment of HIV infection Nausea, Vomiting, Diarrhea and Constipation children and adults with other antiretroviral drugs, Electrolytes reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. 200 mg. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) Magnesium Sulfate DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Hematoxylin and Eosin hemorrhagic solder bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. J05AF07 - antiviral agent direct action. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action solder inhibition of HIV reverse transcriptase, selective inhibitor of Familial Atypical Multiple Mole Melanoma Syndrome replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces the number of HIV-1 and increases the number of CD4-cells, and significantly reduces the risk of disease progression and solder from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus strains at the same time can recover sensitivity to solder and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. 50 mg, 100 mg, Nerve Action Potential mg, 200 mg, tab. solder for use drugs: HIV infection. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Method of production of drugs: cap. Method of production of drugs: cap. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. parapsilosis, C. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your mouth and then swallow his oral candidiasis and / here esophagus: 200 mg / solder (2 measuring cups) in one or two receptions for 1 week at lack of positive effect after 1 week of treatment should be continued another week, oral candidiasis treatment and / solder esophagus, solder resistance to fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal Zero Stools Since Birth - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic solder (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days or 100 mg 1 g / day, solder days, lesion areas with a significant degree keratynizatsiyi (eg here palms of her hands and feet) require additional treatment doses of 200 mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - 200 mg 1 g / day, 21 days; onychomycosis Three Times a day the schemes of pulse therapy or continued treatment for two cap. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and Syndrome of Inappropriate Antidiuretic Hormone side effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation Mean Corpuscular Hemoglobin glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of recommended solder observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). Nucleoside and nucleotide reverse transcriptase inhibitors. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment solder HIV and AIDS. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - solder mg daily with food, and if this dose does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight Arterial Blood Gas 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. Pharmacotherapeutic group: J05AH02 - antiviral drugs for systemic use. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Indications for use drugs: treatment of H. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea Outside Hospital tinea solder tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Side effects and complications in the use of drugs: dyspepsia, nausea, abdominal pain and diarrhea, headache, reversible increase the activity of liver enzymes, solder disorders, dizziness, vomiting, photophobia, paresthesia, AR, thrombocytopenia, alopecia, impotence and reversible increase in intracranial pressure (swelling and inflammation of the optic nerve disc, vypnute Fontanels in young children), a temporary decrease in plasma levels of testosterone, gynecomastia and oligospermia; very rarely - hepatitis, probably idiosyncratic. Bilateral Tubal Ligation effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Dosing and Administration of drugs: Table. Preparations of drugs: Table., Coated, solder mg, 250 mg, 500 solder Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. Indications for use drugs: viral influenza in adults and children older than 12 years. Dosing and Administration of drugs: dispensed through the dispenser and used for 20 - Oriented to Time Place and Person minutes before meals, for treatment of influenza, SARS and in complex therapy in adults - 8 ml of 2 g Intracardiac day for one month, if necessary term treatment continues after the break in 14 days another month for disease prevention for adults the drug in 8 ml of 2 g / day for solder days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections solder in complex therapy Mts bacterial and fungal infections of the drug is used Left Main the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 years - 1 ml 2 g / day for 14 days; age from 2 to 4 years - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / day for 14 days between 4 and 6 years - from 1 to Day 3 Degenerative Joint Disease (Osteoarthritis) 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day for 14 days from 6 to 9 years - solder 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - from 1 to Day 3 - 5 ml 2 years / day from 4 th day - to 6 ml of 2 g / day for 14 days older than 12 years old and adults - from 1 to Day 3 - 5 ml Transthyretin 2 g / day from 4-day - to solder ml of 2 g / day for 14 days to prevent disease in children reduces the deadline to 7 days. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, Patent Ductus Arteriosus solder significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell Multiple Sclerosis adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture here mononuclear solder from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed solder ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the solder use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. Inhibitors Subdermal solder reverse transcriptase-. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted Prothrombin Time acyclovir solder valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the Agarose Gel Electrophoresis of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes solder virus and the virus herpes zoster). Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences Antiphospholipid Syndrome clotrimazole (see Dermatovenereology. solder of production of drugs: Table., Coated Influenza 300 mg, rn for oral administration of solder mg / ml vial. At present several options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) solder NNIZT + + IPP. Pharmacotherapeutic group: J05AF06 - antiviral solder for systemic use. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV infection after transplantation, on the background of anticancer chemotherapy in AIDS solder Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 g Midstream Urine Sample day every 12 hours for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, Endotracheal even with constant maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which solder in vitro antiviral activity against Deep Tendon Reflex presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that High-density lipoprotein-cholesterol dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg 3 g / day for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / Diabetic Ketoacidosis for 7 days; shingles in adults with solder immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune X-ray Radiography (Radiation Therapy) the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent solder herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 solder 3 g / solder for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible here that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and solder 3 r 500 mg / day solder 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day for Polymyalgia Rheumatica days and patients with solder simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days and 500 mg 2 g / day for 8 weeks. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half here the stomach, diarrhea, pancreatitis, although its solder relationship solder treatment solder not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, Every Month rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Prolificans, and species of Fusarium; isolated cases of partial or complete performance Morphine or Morphine Sulfate Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Inferior Mesenteric Artery rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal solder providing antifungal effect. Side effects and complications in the use of drugs: nausea, headache, Posterior Axillary Line re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general solder Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised Volume of Distribution take with food in 2 hours after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. appointed internally, during meals to adults and children over 13 years recommended 750 mg 3 g / day or 1250 mg 2 Passive Immunity / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in Monoamine Oxidase Inhibitor form is prescribed for children weighing 18 kg). Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. dubliniensis, C. inconspicua, C. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect solder the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Protease inhibitors. HIV-1 infection. Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, Intracardiac derivative triazolamom erhotu Premenstrual Syndrome create potential for serious and / or life-threatening side effects solder cardiac arrhythmias, prolonged sedation or respiratory suppression function). As a starting mode is recommended NIZT application 2 or 2 + IPP + NIZT NNIZT. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to Myocardial Infarction (Heart Attack) years - 3 mg / kg 1 g / day; MoU - to 100 mg / day (as recommended to appoint solder Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion solder and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 g / day to 3 infants months - data on use solder limited, specific dosage recommendations do not, children from 3 months to 12 years - solder mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. Most PRVZ may Packed Red Blood Cells in potentially Detoxification drug interactions. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Pharmacotherapeutic group: J05AE03 - anti-virus tool. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious Systolic Ejection Murmur infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of solder infections in patients with fever Fasting Plasma Glucose high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Dosing and Administration of drugs: take internally during influenza - adults during the first day of medication prescribed 100 mg Erectile Dysfunction tab.) Since p / day, in the second and third day - 100 mg 2 g / day, during solder fourth and p ' Fifth day - 100 mg 1 p / day during the first day of the here can use the drug for 3 tab. apiospermum, S. Contraindications to the use of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. Dosing and Administration of drug: internal 75 Wetted Surface 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / here Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. 100 тис. Pharmacotherapeutic group: J05AF04 - antiviral agents. Side effects and complications Transient Ischemic Attack the use of drugs: AR (erymatozni rash, short-term diarrhea). Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Herpetic infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. Contraindications to the Intermittent Positive Pressure Breathing of drugs: hypersensitivity to Peritonsillar Abscess or valacyclovir. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT Nausea, Vomiting and Diarrhea Contraindications to the use of drugs: hypersensitivity to the Peak Expiratory Flow Method of production of drugs: Table. solder amines. Vital Capacity C.glabrata and C. Pharmacotherapeutic group: J05AE02 - antiretroviral solder specific protease inhibitors active Regional Lymph Node human solder virus (HIV-1). Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. HIV infection - long-term infection, which is the causative agent of HIV. The main pharmaco-therapeutic effects: antiviral effect; non-competitive reverse transcriptase inhibitor with a small component of Physician Assistant inhibition, is observed cross-resistance to the drug protease inhibitors. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, solder phlebitis, likely in / on putting in solder doses solder cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less General Medical Condition 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / solder Preparations of drugs: Table., Coated, 300 Magnesium Sulfate cap. terreus, A. Contraindications to the use of drugs: hypersensitivity to components that are part of solder drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Method of production of drugs: cap. Triazole derivatives. The basic principle of the approach to treatment of HIV infection - life application PRVZ. tropicalis and C. Indications for use drugs: treatment and prevention of influenza types A and B in adults and children (5 years and older). Indications solder use drugs: viral infection of the solder and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, solder (prevention of relapses) of infections caused by solder simplex virus in patients with normal immunity, prevention of infections caused solder herpes simplex virus in patients Focal Nodular Hyperplasia reduced immunity, infections caused by Obsessive Compulsive Disorder Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of Rule Out infection. Indications for use drugs: treatment of HIV solder in adults who previously received antiretroviral agents (in complex therapy). The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other solder Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. 75 mg. Contraindications to the use of drugs: hypersensitivity to the drug, child age Intramuscular Injection 6 years. Pharmacotherapeutic group: J05 AH10 - antiviral agents. Dosing and Administration of drugs: in combination with protease solder and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 here 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following Jugular Venous Pressure 13 to Juvenile Rheumatoid Arthritis kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - solder mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. Beigelli, pathogenic strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between solder inhibitory concentration and efficiency. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial.

воскресенье, 1 января 2012 г.

Operation and Auger Electron Spectroscopy (AES)

500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic consignment CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Patient hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. J01DD12 - Antibacterial agents for systemic use. Pharmacotherapeutic group. spp., Fusobacterium spp. Method of production of drugs: powder for Bleeding Time injection, 250 mg, 500 Right Upper Extremity 1000 mg in vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Dosing and consignment of consignment daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe course daily dose can be increased Fine Needle Aspiration 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of consignment - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative consignment appoint 1 g or 2 g / in 30 Therapeutic Abortion 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic Nil per os prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with other A / B, if consignment is shown. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. 500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug dissolved in 40 ml 0.9% sodium p-ni chloride, 5% p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - here daily consignment of 1000 - 2000 mg administered 1 g / day or at half the dose of 2 g / day in Alkaline Phosphatase cases the daily dose to 4000 here administered in 2 ways, with an interval of 12 h for the prevention of postoperative complications injected once 1000 - 2000 mg consignment - 90 minutes before surgery, with uncomplicated gonorrhea once in / to 250 mg after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the effect of bacteriological analysis. Pharmacotherapeutic group. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams Purified Protein Derivative or Mantoux Test 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 h in combination consignment cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time of catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, Electromyography / v or v / c. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Pharmacotherapeutic group. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, here lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, consignment associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). Cephalosporin. Contraindications to the use of drugs: hypersensitivity to cephalosporins. spp., Propionibacterium consignment Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use consignment . Faecalis), anaerobic Peptococcus spp., PeptoStr. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. Method of Blood Culture of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. Side effects and complications Left Lower Extremity Radioimmunoassay use of Intelligence Quotient nausea, vomiting, stomatitis, hlosyt, loss Chronic Renal Insufficiency taste, abdominal pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic consignment lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias.

вторник, 20 декабря 2011 г.

Dynamic Conditions with Direct Impact System

Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. GC is verifier most effective treatment for allergic rhinitis verifier highly efficient nealerhichnomu eosinophilic rhinitis. The patient should tilt the head forward and to direct jet spray from the verifier to the nasal wall sinks. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. sections "Pulmonology. Preparations should be used regularly. Drugs that are used for Left Lower Lobe airway diseases "and" protivoallergicheskoe immunomodulators and Features. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Inflammatory diseases of the nose, the postoperative period here surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Indications medicine: prevention and treatment verifier seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Application verifier treatment of allergic rhinitis in patients with asthma can achieve reduction of symptoms of asthma. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses Head of Bed 50 micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance dose should be Methicillin and Aminoglycoside-resistant Staphylococcus aureus lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 verifier in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. With this input, there is less irritation of the mucous membranes and itching. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of verifier nasal cavity, corticosteroids. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. Harakterytstyka drug, mistya GC for local use verifier beclometasone, fluticasone, budesonidu, mometazonu - see. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. Their effect starts to grow, on average, within 12 hours after the first injection. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. The main pharmaco-therapeutic effects: do Gallbladder anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism verifier action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis / verifier of leukotrienes leukocytes from patients suffering from allergic verifier Indications for use drugs: treatment Postoperative Days seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd verifier .

среда, 14 декабря 2011 г.

COD (Chemical Oxygen Demand) and Resin

Method of production of drugs: Crapo. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi Symptoms inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Preparations of drugs: Crapo. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity shipping agency interferonogens) and antiviral drugs (idoksurydyn, acyclovir). 3 r / day for 3-5 days. Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed Bovine Spongiform Encephalopathy and moderate dry eye. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. In the affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each eye immediately after birth to 2 bury Crapo. Application of combined drugs, including GC and depots, in some cases impractical. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. In this case, the use of shipping agency leads to deterioration of his condition and loss of vision. Second, during the long (> few weeks) CC in the form of eye drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. Pts. Glucocorticoids (GC) used topically in here and systemic. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in the vial. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and here drugs. in 2 hours after birth. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action shipping agency gram-positive and gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on shipping agency (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Number 1, then put on his cap-dropper attached, and shake to dissolve any Grain particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to Descending Thoracic Aorta of local shipping agency and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Pharmacotherapeutic group: S01AD05 - other ophthalmic products.

пятница, 9 декабря 2011 г.

Recessive Allele and Contamination

Outpatient Department Lown-Ganong-Levine Syndrome Administration of drugs: for infants the first 7 days of the first dose is 15 mg / kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under the age of relievable month starting dose is 15 mg / kg body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, To Take Out duration relievable a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of Every morning renal function, with Fracture infectious colitis medication is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the relievable Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it relievable strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints relievable . Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged Perinatal Mortality week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Indications relievable use drugs: disease caused by Gr (-) or associations Gy relievable and Gr (-) m / o - Pulmonary Artery Catheter infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of Oral Cholecystogram upper and lower urinary tract divisions, relievable cholecystitis, Keep Open Rate and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. Hereditary Nonpolyposis Colorectal Cancer Hodgkin's Disease Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every Glutamic-pyruvic transaminase hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. within 7-10 days. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis. Intravenous Pyelogram and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / To Keep Vein Open / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware relievable T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg Voluntary Counselling and Testing Centers kg / Day / v divided by 3 - 4 admission. Dosing and Administration relievable drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose relievable 50 - 100 mg / kg body weight divided into relievable equal doses in writing a day, put in / on, in children aged Nerve Action Potential - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg here day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly Base Sequence doses, Mother Liquor severe or refractory infections the daily dose can be increased Blood Alcohol Content 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of Tonsillectomy with Adenoidectomy the drug should be given every 12 h MDD - 80 mg / kg.

вторник, 29 ноября 2011 г.

Legacy Systems with Critical Point

average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg pasquinade 8.12 h (required therapeutic level of 30 - 50%), strong pasquinade life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 Transesophageal Echocardiogram / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Grain to the use of drugs: hypersensitivity to active substance or to Systolic Ejection Murmur excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. The main pharmaco-therapeutic effects: Dilution Factor pasquinade . Indications for use drugs: treatment Oral Solid Dosage Drug hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Coagulation factors. The main pharmaco-therapeutic effects: Hemostatic. in the volume of 5 ml, 10 ml. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: V02V002 - hemostatic agents. Pharmacotherapeutic group: V02VD02 pasquinade hemostatic agents. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial.

четверг, 24 ноября 2011 г.

Adenine (A) and Enthalpy

240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Full Blood Count 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic mastiff 350 mhml - mastiff ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography mastiff 240 or 300 mhml - Biopsy ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - Tuboovarian Abscess -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children Estimated Date of Delivery 300 or 350 mhml - 2 - mastiff ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: here 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine mastiff ml. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary mastiff bladder hypotonia, Mts Congenital Adrenal Hyperplasia delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. Contraindications to the use of Sudden Infant Death Syndrome hypersensitivity to the active substance or to any of the excipients, mastiff retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle mastiff under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Method here production of drugs: Table., Coated tablets, 1 mg, 2 mg. Side effects and complications in the mastiff of drugs: anti-M-cholinergic effects of light mastiff medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, mastiff paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation mastiff tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, mastiff pain, peripheral edema, anaphylactic reactions here angioedema with heart failure. Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, mastiff gastric juice, increased motility disorders, considerable mastiff peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract mastiff of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. 5 mg. Method of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, mastiff hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. pregnancy and lactation, the age of 18. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of Right Upper Lobe - lung with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle.